| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -306,672 | -184,235 |
| Stock-based compensation expense | 64,768 | 42,454 |
| Net accretion on marketable securities | -9,177 | -6,990 |
| Change in fair value of related party revenue share liability | -27,280 | -7,470 |
| Other non-cash | -229 | -130 |
| Prepaid expenses and other current assets | -304 | -134 |
| Other assets | 13,092 | 10,961 |
| Accounts payable | 16,785 | 8,117 |
| Accrued expenses and other liabilities | 17,694 | 12,462 |
| Net cash used in operating activities | -201,881 | -131,419 |
| Purchases of marketable securities | 613,723 | 435,251 |
| Proceeds from maturities and sales of marketable securities | 770,589 | 538,146 |
| Net cash provided by (used in) investing activities | 156,866 | 102,895 |
| Proceeds from issuance of common stock, net | 15,082 | 10,309 |
| Payments of equity issuance costs | 6 | 6 |
| Payments of insurance costs financed by a third-party | 0 | 0 |
| Net cash provided by financing activities | 15,076 | 10,303 |
| Net increase (decrease) in cash and cash equivalents | -29,939 | -18,221 |
| Cash and cash equivalents at beginning of period | 145,691 | - |
| Cash and cash equivalents at end of period | 115,752 | - |
Nuvalent, Inc. (NUVL)
Nuvalent, Inc. (NUVL)